Actively Recruiting
A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)
Led by St. Antonius Hospital · Updated on 2025-05-15
180
Participants Needed
1
Research Sites
157 weeks
Total Duration
On this page
Sponsors
S
St. Antonius Hospital
Lead Sponsor
M
Merck Sharp & Dohme LLC
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of this study is to evaluate the effect of two decision aids for renal cell carcinoma (RCC) on the decision-making process and the quality of the decision.
CONDITIONS
Official Title
A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients clinically diagnosed with RCC
- Patients facing a decision which is addressed in the decision aids (T1 tumor or metastatic disease)
- Written informed consent
You will not qualify if you...
- Patients who are not able to fill in a questionnaire or undergo an interview individually
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
St. Antonius Ziekenhuis
Nieuwegein, Utrecht, Netherlands, 3435 CM
Actively Recruiting
Research Team
C
Cato Bresser
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here